Literature DB >> 3004400

Lafora's disease. Comparison of inclusion bodies in skin and in brain.

B L Busard, W O Renier, F J Gabreëls, H H Jaspar, U J van Haelst, J L Slooff.   

Abstract

A patient had the clinical and neuropathologic signs of Lafora's disease. Skin biopsy specimens from the midcalf area confirmed earlier findings by showing numerous periodic acid-Schiff-positive inclusion bodies in eccrine sweat gland duct cells. In our patient, however, inclusion bodies were more abundantly present in the apocrine sweat gland duct cells of the axilla skin. In brain biopsy specimens and autopsy material the same periodic acid-Schiff-positive inclusion bodies were found. From these data it can be stated that skin biopsy of the axilla is the method of first choice in confirming the diagnosis.

Entities:  

Mesh:

Year:  1986        PMID: 3004400     DOI: 10.1001/archneur.1986.00520030082023

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Polyglucosan bodies in intramuscular motor nerves.

Authors:  R A Bernsen; H L Busard; H J Ter Laak; F J Gabreëls; W O Renier; E M Joosten; A G Theeuwes
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Early detection of skin and muscular involvement in Lafora disease.

Authors:  S Iannaccone; M Zucconi; A Quattrini; R Nemni; M Comola; L Taccagni; S Smirne
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 3.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Diagnosis by axilla skin biopsy in an early case of Lafora's disease.

Authors:  G Rubio; C Garcia Guijo; J J Mallada; A Cabello; A Garcia Merino
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

5.  Lafora's disease and brain calcifications.

Authors:  S Oster; E Reske-Nielsen; I Bruun
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.